前列腺癌:先进影像与局灶治疗
本文综述前列腺多参数MRI(mpMRI)、基于MRI的靶向穿刺及MRI引导下微创消融治疗(冷冻消融、激光消融、高强度聚焦超声消融)的现状;标准化解读指南如PI-RADS第2版及MRI靶向穿刺提高了临床显著前列腺癌的检出,影像与影像引导靶向穿刺用于风险分层(Gleason分级/评分与肿瘤分期)对患者管理至关重要。
要点
- 多参数MRI联合PI-RADS第2版标准化解读可提高临床显著前列腺癌的检出。
- MRI引导靶向穿刺获取的Gleason分级/评分与肿瘤分期是风险分层的关键。
- 冷冻、激光、高强度聚焦超声等MRI引导微创消融可在实时或近同步MRI监测下对MRI检出且穿刺证实的肿瘤行局灶或区域热消融。
核心结论
- 引入前列腺多参数MRI、PI-RADS第2版等标准化解读指南及MRI靶向穿刺改善了临床显著前列腺癌的检出。
- 利用影像与影像引导靶向穿刺进行准确风险分层(Gleason分级/评分与肿瘤分期)已成为前列腺癌患者管理的关键。
- MRI引导的冷冻消融、激光消融、高强度聚焦超声消融等微创消融治疗可在实时或近同步MRI监测消融区下,对穿刺证实、MRI检出的肿瘤实现局灶或区域热能量递送。
研究设计与样本
- 本文为综述,评述前列腺多参数MRI、基于MRI的靶向穿刺及MRI引导消融技术。
- 原文未报告检索范围、纳入文献数量及证据分级。
关键影像表现/征象
- 多参数MRI用于前列腺癌检出与定位,标准化解读采用PI-RADS第2版。
- MRI引导微创消融治疗中,消融区在实时或近同步MRI监测下评估。
诊断标准与关键数值
- 标准化解读采用前列腺影像报告和数据系统(PI-RADS第2版)。
- 风险分层依据Gleason分级/评分与肿瘤分期。
临床应用与阅片要点
- 原文未据此给出具体阅片或报告推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
In 2016, it is estimated 180,890 men are newly diagnosed with prostate cancer and 3,306,760 men live with prostate cancer in the United States. The introduction of multiparametric (mp) magnetic resonance imaging (MRI) of the prostate, standardised interpretation guidelines such as Prostate Imaging Reporting and Data System (PI-RADS version 2), and MRI-based targeted biopsy has improved detection of clinically significant prostate cancer. Accurate risk stratification (Gleason grade/score and tumour stage) using imaging and image-guided targeted biopsy has become critical for the management of patients with prostate cancer. Recent advances in MRI-guided minimally invasive ablative treatment (MIAT) utilising cryoablation, laser ablation, high-intensity focused ultrasound ablation, have allowed accurate focal or regional delivery of optimal thermal energy to the biopsy proven, MRI-detected tumour, under real-time or near simultaneous MRI monitoring of the ablation zone. A contemporary review on prostate mpMRI, MRI-based targeted biopsy, and MRI-guided ablation techniques is presented.
引用
- Woodrum DA, Kawashima A, Gorny KR, et al. Prostate cancer: state of the art imaging and focal treatment. Clin Radiol. 2017. PMID: 28385253. doi:10.1016/j.crad.2017.02.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。